biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by frohlir944on Jan 25, 2018 12:26pm

101 Views

Post# 27432820

RE:RE:Successful test of the kayacker low!

BEENTHERE,

if we are going to through out conspiracy theories
Then, Kennedy was shot from the grassy knoll
By Bigfoot, and since it was a abviously a conspiracy
the Alien Greys not only helped, but aided with the clever
get away!

Though no one can prove they had actually BEENTHERE!

Bullboard Posts

Day trading vs. swing trading strategies for small-cap stocks